Cognetivity Neurosciences

Cognetivity Neurosciences

Private Company
Public Company
Subsidiary of
Clinical Trials, R&D


Cognetivity Neurosciences is a medical technology company founded at the University of Cambridge, UK, has developed a five-minute cognitive function test, powered by artificial intelligence. Its Integrated Cognitive Assessment (ICA) is an easy-to-use, sensitive, reliable and hugely scalable test that represents a major advance in monitoring brain health.

Delivered via touchscreen devices and the web, the ICA provides a unique end-to-end solution for measuring cognition. It allows early detection of neurological issues, leading to better outcomes for patients and reduced costs for healthcare systems.

Cognetivity is commercialising the ICA in medical and corporate markets in the USA, Europe, the Middle East and elsewhere. With a global estimated market size for cognitive assessment and training expected to reach $11.4 billion by 2026, rising at a market growth of 26.6% CAG, and more than 350 million over 55s in USA, EU and Middle East, Cognetivity’s unique technology is poised to transform the way that brain health is measured and to generate substantial revenue in the coming years.